Asia Consensus Statements
NCCN has consented to direct non-adapted translations of the Complete Library of NCCN Guidelines® into Japanese by a major, national university in Kyoto, Japan. Please visit the Translational Research Informatics Center’s website for additional information.
Latin America Editions
Middle East & North Africa (MENA) Manuscripts
South Korea Editions
South Korea Translations
Translated versions of the NCCN Guidelines are coordinated by NCCN and with legal permission from NCCN. The NCCN Guidelines are a statement of evidence and consensus of the authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient’s care or treatment. The National Comprehensive Cancer Network makes no representations or warranties of any kind regarding their content, use or application and disclaims any responsibility for their application or use in any way. The NCCN Guidelines are copyrighted by National Comprehensive Cancer Network. All rights reserved. The NCCN Guidelines and the illustrations herein may not be reproduced in any form without the express written permission of NCCN.
© 2013 National Comprehensive Cancer Network, Inc. All rights reserved. The NCCN Guidelines® and illustrations herein may not be reproduced in any form for any purpose without the express written permission of the NCCN. To view the most recent and complete version of the NCCN Guidelines, go online to NCCN.org. NATIONAL COMPREHENSIVE CANCER NETWORK®, NCCN®, NCCN GUIDELINES®, and all other NCCN Content are trademarks owned by the National Comprehensive Cancer Network, Inc.
NCCN Guidelines®: Local Editions – Country-specific clinical practice guidelines in English or the local language(s). They include adaptations accounting for metabolic differences in populations, accessibility of technology, and regulatory status of health care technologies used in cancer management in the specified country. The NCCN Guidelines: Local Editions are developed by the host country's oncology thought leaders in conjunction with NCCN Guidelines Panel Members. Modified NCCN Guidelines are developed to aid clinicians in determining appropriate and effective avenues of care in the specified country.
NCCN Guidelines®: Consensus Statements – Manuscript statements outlining, describing, and rationalizing variations in care within a country or region or across multiple countries within a region as compared to the recommendations of the NCCN Guidelines. An exploratory and analytical account of the impact of genetic variations in metabolism of agents, regulatory environments, and practice standards of participating countries.
NCCN authorizes selected groups to adapt the NCCN Guidelines® to reflect genetic variations in metabolism of agents and regulatory environments of host countries, subject to approval by NCCN and representatives of NCCN's disease-specific panels.
Participating countries select disease-specific representatives to review and suggest modifications to specific NCCN Guidelines®. It is important that the fields of surgical oncology, medical oncology, and radiation oncology are represented for each type of cancer. Representatives are recognized experts in the management of these malignancies in their home countries. In addition, because the process involves the development of consensus through compromise, they are sufficiently influential that they can speak for the general oncology community in their own countries.
Members of each committee receive a copy of the most recent version of the NCCN Guidelines for the specific type of cancer. The members circulate the NCCN Guidelines among a representative group of multidisciplinary physicians in their country to determine areas where local practice is not concordant with the NCCN Guidelines. There is discussion of how the NCCN Guidelines might be adapted to accommodate local circumstances. The representative to the regional meeting is responsible for bringing these recommendations forward to the regional meeting.
A regional meeting is conducted so that all participating representatives can develop a single proposal for adaptation of the disease-specific NCCN Guidelines. Any proposed modification of the NCCN Guidelines must be supported by data.
At this meeting, NCCN Guidelines Panel Members present the data used to develop the NCCN Guidelines and representatives of the regional alliance present proposed changes and the literature that supports them. A discussion of the issues takes place and at the end of the meeting, a consensus is developed regarding an adaptation of the NCCN Guidelines that is acceptable to the NCCN. Any changes from the original NCCN Guidelines are identified in the adaptations.
We welcome the opportunity to explore potential business collaborations with you.
If you have questions about NCCN international programs, please contact Jon Larsen, Manager, Global Business Development.
For general NCCN queries and domestic programs, please visit our main Contact Page.